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Abstract 
The search for microorganisms from novel sources and in particular microbial symbioses 
represents a promising approach in biotechnology. In this context lichens have increasingly 
become subject of research in microbial biotechnology, particularly after the recognition that a 
diverse community of bacteria other than cyanobacteria are additional partners to the 
traditionally recognized algae-fungus mutualism. Here we review recent studies using culture-
dependent as well as culture-independent approaches showing that lichens can harbor diverse 
bacterial families known for the production of compounds of biotechnological interest and 
that several microorganisms isolated from lichens, in particular Actinobacteria and 
Cyanobacteria, can produce a number of bioactive compounds, many with biotechnological 
potential. 
Keywords: lichens - bacteria - Actinobacteria - Cyanobacteria- biotechnology.
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Introduction  
Recently, the World Health Organization (WHO) produced a global map of antimicrobial 
resistance and issued a warning that a ‘post-antibiotic’ world could soon become a reality and 
has already started (Woolhouse and Farrar 2014). Therefore, the quest for new drugs from 
microbial sources is currently at a crossroads, where on one hand it is widely thought that the 
discovery of novel compounds has passed its “golden era” with many pharmaceutical 
companies abandoning or downscaling their microbial natural products research, while on the 
other hand, full genomic sequencing and metagenomic research shows that a large number of 
“silent” or novel biosynthetic pathways exist (for reviews see Brady et al. 2009 ; Ochi and 
Hosaka 2013), promising to lead to novel bioactive compounds produced via heterologous 
expression (e.g. Chang and Brady 2013). The continued search for microorganisms from 
novel sources represents an effective strategy forward towards drug discovery. In this context 
microbial symbioses are of particular interest, since increasing evidence supports the 
hypothesis that microbial bioactive compounds, such as those used as antibiotics, might be 
involved in microbe-microbe and microbe-host communication (Yim et al. 2007; Yoon and 
Nodwell 2014). An example supporting this hypothesis, is the fact that many interesting novel 
bioactive compounds of microbial origin have been discovered in marine sponges, known to 
harbor complex symbiotic microbial communities (see Fuerst 2014 for a review).  
Lichens are a well-recognized, self-supporting, mutualistic symbiosis between a 
dominant fungal partner (mycobiont) that provides shelter for one or several photosynthetic 
green algae and/or cyanobacteria (photobionts) forming a unique symbiotic structure, the 
lichen thallus, (De Bary 1879; Frank 1876; Schendener 1860 reviewed in Honegger 2000). 
Lichen-forming fungi have evolved for at least 400 million years (Taylor et al. 1995). The 
lichen thallus is well-adapted to a wide variety of specific ecological niches, often including 
extreme environmental conditions (e.g. extreme temperatures, periodic desiccation, high 
levels of UV radiation). At least some of the mechanisms to cope with these extreme 
conditions are of a chemical nature (e.g. UV screens, cryoprotectants, osmolites) providing 
leads and inspiration for biotechnological development. It also appears that allelopathic 
compounds by the holobiont could play a role in the persistence of lichens. Despite estimated 
individual ages of decades to centuries, there are no reports of destructive bacterial infections 
in lichens. The capacity of produce a broad range of interesting chemical compounds help 
explain the fact, that lichens have been historically also used as sources of pigments, 
perfumes, human medicines etc. (Rikkinen 1995).  
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A number of chemical structures have consistently been associated with lichens and 
due to their presence in axenic culture or other non-lichenizing fungi, it is generally accepted 
that they are produced by the mycobiont. Those include repeats of aromatic acids such as 
orsellinic acid (depsides, depsidones and usnic acids) that are believed to be synthesized by 
non-reducing fungal polyketide synthases (Huneck and Yoshimura 1996; Robinson 1999), 
that have been directly recovered from lichens (i.e. Grube and Blaha 2003; Muggia and Grube 
2010 ; Schmitt et al. 2008). The diversity of these major compounds have been subject of 
recent reviews and catalogues (Boustie and Grube 2005; Elix 2014; Molnár and Farkas 2010; 
Shrestha and St Clair 2013; Shukla et al. 2010; Stocker-Woergoetter 2008) and therefore we 
will focus here on those produced by other microorganisms, in particular Bacteria, although 
we cannot rule out that these bacteria can be also involved in the biosynthesis or conversion of 
major compounds found in lichens. 
 
Culturable bacteria of biotechnological interest  
While the presence of microorganisms other than the mycobiont and the photobiont in 
the lichen holobiont has long been known by isolation techniques (Uphof 1925; reviewed in 
Cardinale et al. 2006), systematic attempts to study these organisms have only recently been 
carried out. One early study (Gonzalez et al. 2005) published 10 years ago clearly 
demonstrated that lichens are sources of bioactive microorganisms. That study focused on 
Actinobacteria by employing a targeted isolation strategy using nalidixic acid (an inhibitor of 
Gram-negative bacteria) as well as heat-treatment prior to cultivation. A standard medium 
(Yeast Malt Extract) was used for isolation from 25 terrestrial lichen samples from Hawaii, 
Alaska and the Reunion Islands. The lichens species were not identified and the samples were 
just classified as saxicolous (i.e. rock associated; 6 from Alaska, 5 from Hawaii) or 
arboricolous (i.e tree-associated; 5 from Hawaii and 9 from the Reunion Islands). A large 
number (337) of strains were obtained, and identified based on DNA fingerprinting and fatty 
acid analysis. Among these strains, 110 belonged to the family Streptomycetaceae, well-
known to produce bioactive compounds. Other actinobacterial families also know for the 
production of bioactive compounds, some belonging to the "rare Actinomycetes" sensu 
Subramani and Aalbersberg (2013), such as Micromonosporaceae (142 strains), 
Pseudonocardiaceae (30 strains) and Thermomonosporaceae (7 strains) were also isolated. 
These strains were screened for genetic potential for biosynthesis (PCR targeting genes 
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involved in polyketide, small peptides, and isoprenoid biosynthesis), as well as antimicrobial 
activity (against Escherichia coli, Staphylococcus aureus and Candida albicans). A high 
percentage of strains (over 60%) potentially contained at least one biosynthetic cluster and 
about 30% of the strains had antimicrobial activity against at least one of the target 
microorganisms. 
Since the pioneering study by Gonzalez and colleagues (2005), many other studies 
have focused on lichen-associated bacteria via cultivation. A number of these studies have 
targeted individual isolates or species, especially for taxonomic purposes or for full genomic 
sequencing (Table 1).  A particular interest was given to biotechnological potential of strains, 
since in several cases isolation selected for Actinobacteria by nalidixic acid addition (9 out of 
23 strains). Finally in some cases [Actinoplanes sp. ATCC55532 (Singh et al. 1997), 
Streptomyces uncialis (Davies et al. 2005), Streptomyces sp. (Motohashi et al. 2010), S. 
cyaneofuscatus (Brana et al. 2015) and Streptomyces sp. (Lavallee 2011)] the focus was 
primarily on the discovery of novel bioactive molecules, with the first strain described in a 
patent (Singh et al. 1997). These strains will be discussed in a later section. It is remarkable 
that in several of these studies there is only a poor description or a complete lack of 
identification of the source lichens.  
A different class of culture-based studies performed a more comprehensive isolation of 
lichen associated bacteria, basing the isolation on criteria other than bioactivity and, except for 
our recent study (Parrot et al. 2015), did not target Actinobacteria (Table 2). The results of 
these studies offer a less biased view of the cultivable bacterial diversity associated with 
lichens, and it is clear that certain bacterial phyla and classes, in particular Alpha- and 
Gammaproteobacteria, Firmicutes and Actinobacteria are frequently isolated from lichens 
(Cardinale et al. 2006; Grube et al. 2009; Selbmann et al. 2010). In addition Bacteroidetes 
seem to be isolated from marine or littoral lichens (Parrot et al. 2015; Sigurbjornsdottir et al. 
2014). Among all isolates, many belong to bacterial families known to contain strains know to 
produce bioactive compounds, enzymes of biotechnological interest such as lipases proteases 
and antagonistic molecules (Table 2). In a few cases this was experimentally tested (Grube et 
al. 2009; Lee et al. 2014), while in others studies this potential was inferred by the presence of 
genes involved in the biosynthesis of polyketides or 16S rRNA similarity to known bioactive 
strains (Parrot et al. 2015). In the latter study the authors focused on the isolation of 
Actinobacteria from marine and littoral lichens, and showed that these lichens were sources of 
bacteria of biotechnological interest, and that the use of Marine Agar, a medium used to the 
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isolation of a broad diversity of marine bacteria, yielded many strains that were not recovered 
with the commonly used Actinomycete Isolation Agar medium, and this did not appear to be 
an effect of salinity (Parrot et al. 2015). Among these stains some appeared to represent novel 
species or even genera. Finally that study compared the 16S rRNA genes to those in the NCBI 
Genbank from bacteria associated with lichens studied using culture independent methods and 
as expected none of the strains appeared to be prevalent in the studied lichens. 
 To obtain a larger representation of lichen associated strains, including strains for 
which only 16S rRNA sequences exist, we searched all 16S rRNA gene sequences present in 
the NCBI Genbank nt database with the query “lichen AND bacteria [orgn] NOT 
Cyanobacteria [orgn] NOT uncultured” and recovered the taxonomy information associated 
with these sequences (associated or not to publications), and obtained somewhat similar 
results, which again might be a reflection of the targeting of Actinobacteria in isolation efforts 
even though this analysis did not include the study of Gonzalez and colleagues and Parrot and 
colleagues that have focused on Actinobacteria (Gonzalez et al. 2005; Parrot et al. 2015). 
Among 511 bacterial strains retrieved, nearly half of isolates (246) belong to Actinobacteria, 
185 to Alphaproteobacteria, 85 to Firmicutes and 59 to the Gammaproteobacteria. Focusing 
on bacterial families of biotechnological interest, about 30% (150 in 511) belong to the 
families Bacillaceae (40), Paenibacillaceae (37), Burkholderiaceae (24), Pseudomonadaceae 
(19), Streptomycetaceae (18), Micromonosporaceae (5), Nocardioidaceae (5) and 
Pseudonocardiaceae (2) known for the production of bioactive molecules. 
Finally, a number of studies have attempted to cultivate cyanobacteria (mostly the 
main photobionts) from lichens (Table 3). In addition to the search of bioactive compounds of 
pharmacological the main interest a few of these studies was the production of toxins or other 
metabolites by these cyanobacteria strains, and in particular hepatoxins relevant to public 
health (see Dittmann et al. 2013 for a review). Extensive genetic and chemical screening of 
lichens of the lichen order Peltigerales, known of for their association with the cyanobacterial 
genus Nostoc have clearly shown that a non-negligible (about 5 % of specimens) contain 
microcystins or nodularins (Kaasalainen et al. 2013) most likely produced by symbiotic 
cyanobacteria. In addition to the original interest for public health, the use of microcystin 
congeners has also recently been proposed for cancer therapy (Niedermeyer et al. 2014), 
demonstrating the interest in these lichen associated cyanobacteria. 
 7 
Summarizing, existing information from culture-based studies clearly show that 
lichens can be a source of bacterial strains of biotechnological interest such as Bacillus, 
Paenibacillus, Pseudomonas, Burkholderia and Nostoc. Regarding Actinobacteria, interesting 
strains in this phylum were isolated even without selective approaches. Studies using selective 
approaches yielded a higher diversity of Actinobacteria and in particular of non-Streptomyces 
genera, including possible new species. It also appears that cyanobacterial symbionts can be a 
promising source of bioactive molecules of biotechnological interest. 
 
Strains known to produce bioactive compounds 
Despite the large number of bacterial strains of relevance to drug discovery isolated 
from lichens, the presence of structurally-identified bioactive molecules have only been 
reported for a few of these strains (Streptomyces uncialis and Actinoplanes sp. ATCC55532, 
Streptomyces sp. RI104-LiC106, Streptomyces sp. RI104-LiB101, Streptomyces sp. L-91-3 
Nostoc sp., Nostoc sp. ATCC 53789 and Nostoc sp. IO-102-I Tables 1 and 3). In addition, 
identified molecular structures have also been reported for strain S. cyaneofuscatus T178 
reported as being phenotypically and metabolically indistinguishable from S. cyaneofuscatus 
M-27. The relative small number of reported molecules is partly due to the fact that interest in 
lichen-associated bacteria is relatively recent but also likely due to the fact that publications 
tend to focus on novel chemical structures, and thus presence of known compounds, even in 
novel organisms, is seldom reported.  In the following paragraphs we describe several lichen-
associated bacteria for which bioactive compounds have been identified. The molecular 
structures of selected compounds are presented in Figure 1. 
Actinoplanes sp. ATCC55532 was isolated from a non-identified arboricolous lichen 
from Spain has been reported to produce actinoplanic acids A and B (Singh et al. 1997) . This 
patent also claims that actinoplanic acid B (1) inhibits farnesyl-protein transferase (FPTase) 
and the farnesylation of the oncogene protein Ras, in vitro at (IC50 at 50 nM) and thus have a 
potential for the treatment of colorectal carcinoma, exocrine pancreatic carcinoma and 
myeloid leukemias.  
Streptomyces uncialis, isolated by Davies and co-workers from a Cladonia uncialis, 
has been the been well characterized and reported to produce the enediyne antibiotic 
uncialamycin (2) highly active against Escherichia coli, Staphylococcus aureus as well as 
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Burkholderia cepacia (Davies et al. 2005). The same strain produces the alkaloids 
Cladoniamides A-G with the latter (3) showing significant in vitro toxicity against MCF-7 
breast cancer cells at 10 µg/mL (Williams et al. 2008). A second lichen-derived Streptomyces 
strain isolated from lichens by the Davies’ group (L-91-3) was reported to produce several 
inhibitors of Catepsin K (a protease identified as a drug target for osteoporosis therapy 
Yasuda et al. 2005). These molecules included the oligopeptide Antipain and two analogues 
described as vince-2 and lichostatinal (Lavallee 2011). 
Strains RI104-LiC106 and RI104-LiB101 reported as belonging to a new Streptomyces 
species have been shown to produce JBIR-88 (4), a 1,1-dichlorocyclopropane-containing 
angucycline and JBIR-89 (5), a butenolide. JBIR-88 was cytotoxic to HeLa and ACC-MESO-
1 cells IC50 36 and 52 mM, respectively. It also showed antibacterial activity against 
Micrococcus luteus, but not against Candida albicans and E. coli (Motohashi et al. 2010).  
S. cyaneofuscatus M-27 was isolated from the algae Fucus spiralis and reported to be 
metabolically indistinguishable from S. cyaneofuscatus T-178 isolated from an unidentified 
lichen. This strain was reported to produce a number of anthracycline family antitumor 
antibiotics daunorubicin, cosmomycin B (6) and galtamycin B and the antifungal macrolactam 
maltophilin (7). Daunorubicin is already used as a drug for cancer chemotherapy, 
cosmomycin B shows in vitro cytotoxicity against the KB human epidermoid carcinoma cell 
line (Ando et al. 1985) and galtamycin B shows in vitro cytotoxicity against gastric 
adenocarcinoma (HMO2), breast carcinoma (MCF7), and hepatocellular carcinoma (HepG) 
cell lines at (10 µg/mL Antal et al. 2005). Maltophilin has been shown to inhibit the growth of 
a number of fungi (Jakobi et al. 1996). It has to be noted however that all molecules reported 
to be produced by S. cyaneofuscatus M-27 were only identified based on their HPLC retention 
time and UV-vis spectra (Brana et al. 2015). 
Nostoc strain. ATCC 53789 was isolated from lichens and was shown to produce 
cryptophycin 1 (8), which was originally patented for its antifungal properties (Moore and 
Patterson 1997). Further analysis of other molecules in this class resulted in the discovery of it 
biosynthetic pathway, and of a strategy for chemoenzymatic synthesis of analogous molecules 
(Magarvey et al. 2006), Furthermore, a synthetic analog (cryptophycin 52) achieved Phase II 
clinical trials for lung cancer therapy (Edelman et al. 2003) at which stage development was 
stopped. More recently, the use of cryptophycin analogs in antibody-drug conjugates has also 
been proposed (Verma et al. 2012). 
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An unnamed Nostoc sp. strain isolated from Peltigera canina was shown to produce 
the chlorine containing nostoclides I and II, which have moderate toxicity (10 µg/ml) against 
cell lines Neuro-Pa CCL 131 and KB CCL17. Nostoc sp. strain IO-102-I isolated from a 
Pannaria pezizoides from Finland, appears in turn to be the only lichen-derived isolate shown 
to produce a number of microcystins (Oksanen et al. 2004), despite the report that many 
lichen specimens contain this class of molecules.  
Finally, a recent study has reported that a Nostoc sp. strain N6 isolated from Peltigera 
membranaceae produces nosperin (9) a pederin like-molecule, produced by a predominantly 
trans-AT polyketide synthase biosynthetic pathway (Kampa et al. 2013). In this remarkable 
study Kampa and colleagues predicted - using shotgun metagenomic sequencing and 
sequence-based biosynthetic analysis - that a Nostoc strain was likely to produce a pederin-
like molecule. Based in this information the authors were able to perform targeted isolation of 
the cyanobacterium that was followed by mass cultivation and isotopic incorporation to 
finally determine the structure of this molecule present in very low abundance, linking it to its 
most likely biosynthetic pathway (Kampa et al. 2013). 
In summary, although interest in lichen-associated biotechnologically relevant bacteria 
is relatively recent, a number of bioactive and structurally identified molecules were produced 
by Actinomycetes and Cyanobacteria isolated from lichens, with some novel structures of 
high potential and some already in drug development. 
 
The yet untapped potential seen through cultivation independent approaches 
For the past 10 years, lichen-associated bacteria have been subject of an increasing 
number of cultivation-independent molecular surveys. These studies employed a number of 
techniques including fingerprinting of rRNA genes, fluorescence in situ hybridization and 
sequencing from mixed microbial populations (e.g., Cardinale et al. 2006, 2008, Grube et al. 
2009). The cultivation-independent approaches used DGGE, SSCP, 16S rRNA gene cloning 
and Sanger sequencing, or next generation sequencing (454 pyrosequencing, Illumina 
sequencing) either of PCR amplified 16S rRNA genes or of shotgun fragments (Table 4). 
These studies clearly show a difference in abundance and diversity of culture-dependent 
versus -independent fractions of the lichen associated bacterial communities and demonstrated 
that the bacterial communities of most lichens studied so far are dominated by bacteria 
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belonging to the Alphaproteobacteria class of the Proteobacteria, with other taxa such as the 
Beta-, Gamma- and Deltaproteobacteria and the phyla Bacteroidetes, Actinobacteria, 
Firmicutes and Verrucomicrobia frequently present (Grube et al. 2015). The general 
relationships between microbiomes, lichen morphology, photobiont and substrates have 
recently been summarized by Aschenbrenner and colleagues, indicate that most lichens do 
have Alphaproteobacteria as predominant symbionts, although at a finer taxonomic resolution 
some patterns emerge such as the importance of Acidobacteria and Acetobacteraceae 
(Rhodospirillales) in acid rock and soil lichens, and higher actinobacterial percentages in 
intertidal lichens (Aschenbrenner et al. 2014). 
 Even though lichens are hosts of phyla and classes known to contain species with 
potential of producing bioactive compounds, such as the Actinobacteria and Firmicutes, an 
analysis of diversity at a finer resolution indicates that although present, bacterial families of 
biotechnological interest (apart from the Cyanobacteria) are relatively minor members of the 
community, with the Burkholderiaceae and Paenibacillaceae representing at a maximum one 
percent of the community, while the other families are about 10 to 100 times less abundant 
(Table 4). That does not decrease the potential for biodiscovery based on cultivation 
approaches, as it has been clearly pointed out in the previous sections. However, lower 
relative abundances have to be taken in account when evaluating the role of these organisms 
and their bioactive molecules to the lichen symbiosis (i.e. their spatial localization and 
aggregation becomes important), and during the design of culture independent strategies to 
uncover the biotechnological potential of these microorganisms (i.e. via metagenomics). 
 One interesting point emerging from cultivation independent studies, is the presence 
Myxococcales in relative abundances of the same range or sometimes higher than those of 
Actinobacteria (Table 4). This group of microorganisms is particularly interesting with large 
genomes and potential to the production of bioactive compounds (Dworkin 2001). 
Myxobacteria have a particular life style (Dworkin 2001) which is also conducive to the use 
of targeted isolation (e.g. Zhang et al. 2003), but to date a single lichen-associated 
Myxobacteria [ATCC 25944 (M 155)] has been described (McCurdy 1971). This is 
interesting, since in the original description of the Myxobacteriaceae Thaxter indicates that a 
number of species including Corallococcus (Myxococcus) coralloides and Melittangium 
(Chondromyces) lichenicolus were associated with lichens (Thaxter 1892), and myxobacteria 
have been reported as associated to decaying lichens (Reichenbach 1999) . 
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 Regarding the application of metagenomic techniques in biotechnological 
development of lichen-associated bacteria, the nosperin example discussed above (Kampa et 
al. 2013) clearly shows that the direct shotgun sequencing and assembly and analysis of 
cyanobacterial genomes can lead to the discovery of potentially new novel interesting 
molecules and biosynthetic pathways, as well as guide targeted cultivation of microorganisms 
of interest. Other recent studies have applied shotgun sequencing targeting lichen associated 
bacteria (Grube et al. 2015; Sigurbjornsdottir et al. 2015), but the complexity of community 
did not allow the assembly of contigs long enough to permit analyses of biosynthetic 
pathways. A focus on lichens with chlorophyte symbionts, with a possible physical separation 
of bacteria (or bacterial DNA) would increase the chance of assembling larger genomic 
fragments and allow a better access to biosynthetic pathways, in particular those possibly 
present in the genomes of dominant Alphaproteobacteria symbionts (with the caveat that 
these organisms are not the most prolific in terms of the biosynthesis of bioactive molecules). 
Other techniques such as the construction and massive screening of fosmid libraries (e.g. 
Freeman et al. 2012) or single cell genomics (e.g. Wilson et al. 2014) likely represent better 
alternatives to access the genomes of rarer bacteria from lichens. However, the fact that many 
of the bacteria with biosynthetic potential present in lichens belong to groups for which 
targeted cultivation methods do exist, seem to indicate that for the near future, cultivation 
based-methods might be in fact a more promising approach.  
 In a first metaproteomic study, proteomics using one-dimensional gel electrophoresis 
combined with LC-MS/MS and normalized spectral counting was applied to characterize the 
active proteins of the Lobaria pulmonaria symbiosis (Schneider et al. 2011). Interestingly, not 
only the fungal partner was characterized by a rich secondary metabolism, also the bacterial 
partners showed a high activity supporting the hypothesis of biotechnologically relevant 
bacteria in symbioses.  
 
Further biotechnological potential of lichen-associated bacteria 
 Irrespective of their capacity to produce small metabolites, lichen-associated bacteria 
have a wider biotechnological potential. According to a pioneering study by Gasser et al. 
(2011), one third of the detected lichen-associated bacteria have the potential to produce PHA 
biopolymers, yet, the strains isolated also showed a remarkable high antagonistic potential 
against plant pathogens. Up to 100% were antagonistic especially against leave pathogens, 
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such as Alternaria alternata. Similarly, antagonistic properties were also detected by Kim et 
al. (2013, 2014). Cernava et al. (2015) studied the antagonistic potential of a lichen-associated 
bacterial community of the lung lichen (Lobaria pulmonaria) with an integrative approach 
combining isolate screening, multi-omics techniques and high resolution mass spectrometry. 
The highly diverse microbiome contained an abundant antagonistic community dominated by 
Stenotrophomonas, Pseudomonas and Burkholderia. In these examples, the precise principle 
of antagonisms, and whether this also comprises interesting novel compounds, still needs to 
be established. The examples for antagonisms will be continued with future studies, especially 
after Zachow et al. (2013) proposed a promising screening strategy using plant rhizospheres 
as bait for lichen-associated bacteria. These studies further support lichens as important 
reservoirs of bacteria that are biotechnologically attractive. 
 Considering the high estimate of 18500 described lichens, much work apparently lays 
ahead of us to exploit their biotechnological potential. A more focused search for the most 
promising habitats and species may be guided by ecological knowledge. This possibly 
includes habitats where microbial regulation and competition becomes a major factor due to 
certain abiotic parameters, such as temperature and water availability. Thus expected hot spots 
for further research will include warmer zones such as tropical rain forests, or those, which are 
more frequently exposed to water inundation, including water streams or intertidal habitats.   
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Figure 1. Structures of some molecules produced by lichen associated bacteria (1) 
actinoplanic acid B, (2) uncialamycin, (3) cladoniamide G (4) JBIR-88 (5) JBIR-89 (6) 
cosmomycin B (7) maltophilin (8) cryptophycin 1 (9) nosperin
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Table 1. Bacterial strains isolated from lichens that  1) are officially described and/or 2) have a fully sequenced genome and/or 3) 
produced molecules that have been identified 
Strain Phylum or Class - Famlly Location, Lichen  Isolation 
Medium 
Nalidixic 
Acid 
Reference 
Corallococcus sp.                   
ATCC 25944 
Deltaproteobacteria -           
Myxococcaceae 
n.r. n.r. no McCurdy et al, 1971 
Actinoplanes sp.                      
ATCC 55532 
Actinobacteria -           
Actinoplanacee 
Spain, Madrid                                             
Unidentified 
ISP3 no Singh et al 1997 
Streptomyces 
uncialis "ex Julian 
Davis et al." 
Actinobacteria -           
Streptomycetaceae 
Canada, British Columbia                            
Surface of Cladonia uncialis 
n.r. no Davies et al. 2005 
Herminiimonas 
saxobsidens NS11 
Betaproteobacteria - 
Oxalobacteraceae 
Turkey, Mugla                               
Lichen-Rock interface 
Potassium 
Oxalate 
no Lang et al. 2007 
Nocardioides 
exalbidus RC825 
Actinobacteria -           
Nocardioidaceae 
Japan, Izu Oshima Island                    
unidentified 
IAM-A1 no Li et al 2007       
Schumannella 
luteola KHIA 
Actinobacteria - 
Microbacteriaceae 
Japan, Tokyo                         
unidentified 
Modified 
Dettmer 
no An et al 2008 
Leifsonia lichenia 
2Sb 
Actinobacteria -           
Microbacteriacee 
Japan, Tokyo                         
unidentified 
Modified 
Dettmer 
no An et al 2009 
Mucilaginibacter 
lappiensis ANJLI2 
Bacteroidetes-
Sphingobacteriaceae 
Finland, Lapland                          
Decaying Lichen 
Lichenin no Mänistö et al 2010 
Streptomyces sp. 
RI104-LiC106 
Actinobacteria -           
Streptomycetaceae 
Japan, Rishiri Island                  
unidentified 
HV agar yes Motohashi et al 2010 
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Streptomyces sp. 
RI104-LiB101 
Actinobacteria -           
Streptomycetaceae 
Japan, Rishiri Island                  
unidentified 
HV agar yes  Motohashi et al 2010 
Streptomyces sp. L-
91-3 
Actinobacteria -           
Streptomycetaceae 
Canada, British Columbia                            
Unidentified 
n.r. nr Lavallée 2011 
Frondihabitans 
cladoniiphilus 
CafT13 
Actinobacteria - 
Microbacteriaceae 
Austrian alps TYE no Cardinale et al. 2011 
Actinomycetospora 
iriomotensis IR73-
Li102 
Actinobacteria -           
Pseudonocardiaceae 
Japan, Iriomote Island                               
crustose unidentified 
humic
acid 
vitamin 
agar 
yes Yamamura et al. 
2011a 
Actinomycetospora 
rishiriensis RI109-
Li102 
Actinobacteria -           
Pseudonocardiaceae 
Japan, Rishiri Island                  
unidentified 
humic 
acid 
vitamin 
agar 
yes Yamamura et al. 
2011b 
Sphingomonas sp 
PAMC26605 
Alphaproteobacteria - 
Sphingomonadales 
Arctic Norway (Svalbard)                                
Ochrolechia sp. 
n.r. no Shin et al 2012 
Sphingomonas sp 
PAMC26621 
Alphaproteobacteria - 
Sphingomonadales 
Arctic Norway (Svalbard)                                  
Cetaria sp. 
n.r. no Lee et al 2012a 
Sphingomonas sp 
PAMC26617 
Alphaproteobacteria - 
Sphingomonadales 
Arctic Norway (Svalbard)                          
Umbilicaria sp. 
n.r. no Lee et al 2012c 
Sphingobacterium 
cladoniae No.6 
Bacteroidetes-
Sphingobacteriaceae 
Korea, Geogeum Island                                           
Cladonia sp 
LB no Lee et al 2013 
Luteimicrobium 
album RI148-Li105 
Actinobacteria -           
Promicromonosporaceae 
Japan Rishiri Island                        
foliaceous unidentified 
humic 
acid 
vitamin 
yes Hamada et al 2013 
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agar 
Streptomyces 
cyaneofuscatus 
T178 
Actinobacteria -           
Streptomycetaceae 
Spain, Muniellos                                              
Unidentified 
TSA yes Braña et al 2015 
Streptomyces 
cyaneofuscatus T35 
Actinobacteria -           
Streptomycetaceae 
Spain, La Vecilla                                              
Unidentified 
TSA yes Braña et al 2015 
Streptomyces 
cyaneofuscatus 
T140 
Actinobacteria -           
Streptomycetaceae 
Spain, Cuntis                                              
Unidentified 
TSA yes Braña et al 2015 
Streptomyces 
cyaneofuscatus 
T163 
Actinobacteria -           
Streptomycetaceae 
Portugal, Guimarães                                             
Unidentified 
TSA yes Braña et al 2015 
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Table 2. A list of studies that surveyed the diversity of microbial isolates associated with lichens 
Lichen species Lichen origin target of 
isolation 
Medium Potentially interesting families, 
activities or others caracteristics of 
biotechnological interest 
Reference 
Not identified Sitka and Kodiak, 
Alaska Hawaii and 
Reunion Islands 
Biotechnology soil 
extract 
agar, 
humic 
acid agar 
and 
glycerol 
asparagi
ne agar 
Streptomycetaceae, 
Micromonosporaceae, 
Pseudonocardiaceae, 
Thermomonosporaceae. 
Antimicrobial activity, Genes 
involved in biosynthesis of 
secondary metabolites.   
Gonzalez et al. 
2005 
Cladonia digitata, C. 
rangiferina, C coniocracea, 
C. pyxidata, C. coccifera, 
Pseudoevernia furfuracea, 
Hypogminia physodes, 
Rocella phycopsis*, R. 
fuciformis* 
Styria, Austria 
and Normandy, 
France* 
Untargeted, 
Diazotrophs 
TYE, 
Sugar-
rich N 
free 
Bacillaceae, Paenibacillaceae, 
Burkholderiaceae, 
Micromonosporaceae, 
Streptomycetaceae, 
Streptosporangiaceae 
Cardinale et al. 
2006 
Canoparmelia caroliniana, 
Canoparmelia crozalsiana,  
Canoparmelia texana, 
Parmotrema sancti-angeli  
Parmotrema tinctorum 
Rain Forest, Brazil Diazotrophs N-free 
NFb 
Pseudomonadaceae Liba et al. 2006  
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Cladonia arbuscula, 
Lecanora polytropa,  
Umbilicaria cylindrica 
wind-swept heath 
above the tree 
line Austria 
Untargeted R2A Bacillaceae, Paenibacillaceae 
Burkholderiaceae. Chitinolytic, 
glucanolytic, and proteolytic 
activity, hormone production 
(indole-3-acetic acid). Antagonistic 
activity 
Grube et al. 
2009  
Lecanora fuscobrunnea, 
Umbilicaria decussata, 
Usnea antarctica, 
Xanthoria elegans 
Antarctic Psychrophiles TYE Pseudomonadaceae, Bacillaceae Selbman et al 
2010  
Cladonia sp. Cladonia 
rangiferina 
Spagnun Bog, 
Tundra; Russia 
Acidobacteria Lichen 
extract, 
M3 
None, as only Acidobacteria isolated 
described 
Pankratov 
2012  
Ochrolechia sp Arctic Antimicrobial      
Antioxidants 
MY/R2A Burkholderiaceae, 
Sphingomonadaceae. Antimicrobial, 
Antioxidant, Prod. Carotenoids 
Kim et al. 2014  
Usnea sp., Cladonia 
borealis, Psoroma sp., 
Stereocaulon sp., 
Umbilicaria sp., Cetraria 
sp., Ochrolechia sp. 
Antarctic and 
Arctic 
Biotechnology R2A, 
ISP4, MY 
Streptomycetaceae, 
Paenibacillaceae, Burkholderiaceae, 
Pseudomonadaceae; Extracellular 
proteases, Lipases 
Lee et al. 2014 
Lecanora helicopis, 
Verrucaria ceuthocarpa, 
Hydropunctaria 
maura, Caloplaca 
verruculifera 
Northern Iceland 
seashore Crag, 
Untargeted Marine 
Agar 
Streptomycetaceae, Bacillaceae Sigurbjörnsdòti
r et al. 2014 
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Lobaria pulmonaria Styria, Austria Biotechnology R2A, 
SCA, 
ISP2 
Bacillaceae, Paenibacillaceae, 
Burkholderiaceae, 
Pseudomonadaceae, 
Nocardioidaceae, 
Xanhtomonadaceae        
Antagonisitic activity, Volatile 
Organic Compound production, 
Spermidine production, hydrogen 
cyanide production 
Cernava et al. 
2015a Cernava 
et al. 2015b 
Lichina confinis, Lichina 
pygmaea, Rocella 
fuciformis, Collema 
auriformis 
Marine, France; 
Riparian, Austria  
Littoral 
Lichens; 
Actinobacteria 
Marine 
Agar, 
AIA,ISP2 
with 
Nalidixic 
acid 
Bacillaceae, Pseudomonadaceae, 
Nocardioidaceae, 
Promicromonosporaceae, 
Pseudonocardiaceae, 
Streptomycetaceae. Pks I and Pks 
II genes. 
Parrot et al. 
2015  
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Table 3. Cyanobacteria strains isolated from lichens with characterized secondary metabolites    
Strain Lichen species Lichen origin Metabolites Described Reference 
Nostoc sp. ATCC 53789 Not described Lichen, Arron Island, 
Scotland 
Cryptophycin 1 Hisrsch et al 1990 
Nostoc sp. Peltigera canina Not reported Nostoclide I and II Yang et al 1993 
Nostoc sp. ATCC 53789 Not described Lichen, Arron Island, 
Scotland 
Nostocyclopeptide A1 and A2 Golakoti et al 2001 
Nostoc sp. IO-102-I Pannaria pezizoides Rock Southern 
Finland 
[ADMAdda5]microcystin-LR    
[DMAdda5]microcystin-LR             
[D-Asp3,ADMAdda5]microcystin-
LR   [ADMAdda5]-XR type variants 
Oksanen et al. 2004 
Nostoc sp N6 Peltigera membranacea Iceland Nosperin Kampa et al 2013 
 
  
 27 
Table 4. Cultivation independent studies broadly targeting the diversity of lichen associated bacteria   
Lichen species Lichen origin Techniques 
applied 
Phyla/Class described, average and 
range of percentage of Total¶, 
Prokaryotes, Bacteria§  
Potentially interesting 
families*, activities or others 
caracteristics of 
biotechnological interest 
Reference 
Cladonia digitata, C. 
rangiferina, C. 
coniocracea, C. 
pyxidata, C. coccifera, 
Pseudevernia 
furfuracea, 
Hypogymnia 
physodes, Roccella 
phycopsis*, R. 
fuciformis* 
Styria, Austria 
and Normandy, 
France* 
ITS 
fingerprinti
ng, 
Sequencin
g of bands 
Gammaproteobacteria       
Actinobacteria           
Betaproteobacteria  
Bacillaceae Cardinale et al. 
2006 
Cladonia arbuscula Styria, Austria  FISH, 
SSCP 
Alphaproteobacteria 75% 
Actinobacteria 6%         
Betaproteobacteria 4% 
Not described Cardinale et al. 
2008 
Cladonia cristatella, C. 
cryptochlorophaea, C. 
cf. sobolescens, C. 
peziziformis, C. 
subtenuis, 
Flavoparmelia 
caperata, Parmotrema 
perforatum, Peltigera 
phyllidiosa, Lasallia 
pensylvanica, 
Umbilicaria 
Virginia and N. 
Carolina, USA 
Direct 
Sanger 
sequencing 
of PCR 
products 
using 
universal 
primers 
(RHAPSA-
D) 
Alphaproteobacteria          
Acidobacteria        
Gammaproteobacteria 
None Hodkinson and 
Lutzoni 2009 
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mammulata 
Cladonia arbuscula, 
Lecanora polytropa, 
Umbilicaria cylindrica 
Styria, Austria  FISH, 
SSCP 
Alphaproteobacteria 45-75% 
Actinobacteria 6%     
Betaproteobacteria 4% 
Burkholderiaceaea, 
Pseudomonadaceaea 
Grube et al 2009 
Xanthoparmelia plittii, 
X. somloënsis 
Massachusetts, 
USA 
Pyro-
sequencing 
of 16S 
rRNAs 
Alphaproteobacteria (30-60% §)             
Acidobacteria (~17% §)     
Bacteoidetes + Gammaproteobacteria 
+ Deltaproteobacteria + Fibrobacteres 
(<2% §) 
Not described Mushegian et al 
2011 
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Parmelia sulcata, 
Rhizoplaca 
chrysoleuca, 
Umbilicaria americana, 
Umbilicaria phaea 
Colorado, USA Pyro-
sequencing 
of 16S 
rRNAs 
Alphaproteobacteriab (47%; 30-85%)                         
Acidobacteriab (14%; 4-25%)   
Gammaproteobacteriab (8%; 0-52%)                            
Firmicutesb (7%; 1-13%)      
Verrucomicrobiab (6%; 0-24%) 
Planctomycetesb (5%; 1-10%)  
Actinobacteriab (4%; 0-10%)  
Betaproteobacteriab (1%; 0-4%)      
Bacteroidetesb (3%; 0-8%)  
Deltaproteobacteriab (1% 0-8%)  
Paenibacillaceaeb (1.6%) 
Micromonosporaceaeb 
(0.31%)       
Kineosporiaceaeb (0.25%) 
Burkholderiaceaeb (0.18%) 
Myxococcalesb (0.16%) 
Pseudonocardiaceaeb 
(0.09%)    
Pseudomonadaceaeb (0.03%)   
Actinomycetaceaeb (0.01%)    
Bates et al 2011 
Hydropunctaria 
maura, Ophioparma 
ventosa, Pertusaria 
corallina, Rhizocarpon 
geographicum 
SW Norway DGGE, 
Clone 
libraries 
Alphaproteobacteriac (30% §)     
Betaproteobacteriac (21% §)    
Actinobacteriac (~16% §)     
Acidobacteriac (~10% §)  
Cyanobacteriac (8% §)          
Firmicutesc (7% §)               
Chloroflexic (2% §)           
Bacteroidetesc (1% §) 
Burkholderiaceaec 
Pseudomonadaceaec 
Nocardioidaceaec 
Bjelland et al 
2011 
Lobaria pulmonaria Styria, Austria  FISH, 
SSCP 
Alphaproteobacteria (47.3-93.9%) Burkholderiaceaed  Cardinale et al 
2012a 
Cetraria islandica, 
Lobaria pulmonaria, 
Lecanora polytropa, 
Cladonia arbuscula, 
Umbilicaria cylindrica, 
Styria, Austria  FISH, 
SSCP 
Alphaproteobacteria 15.5-80% 
Betaproteobacteriae 0-55% 
Gammaproteobacteriae 0-28% 
Actinobacteriae 0-6%  
Not described Cardinale et al 
2012b 
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Cladonia coccifera 
Solorina crocea Styria, Austria  Pyro-
sequencing 
of 16S 
rRNAs† 
Acidobacteria (42.4-66.4%)     
Proteobacteria (11-30%)             
Planctomycetes (7.2-25.2%) 
Actinobacteria (1.3-5.2%)                 
Myxococcales Grube et al 2012 
21 samples of 
Cladonia sp., 
Flavocetraria sp., 
Ophioparmasp., 
Umbilicaria sp., Usnea 
sp., Dictyonema sp., 
Leptogium sp., 
Peltigera sp., Sticta 
sp. 
Cerro de la 
Muerte, Costa 
Rica                        
Alaska, USA               
North Carolina, 
USA 
Pyro-
sequencing 
of 16S 
rRNAs† 
Alphaproteobacteriaf (60%; 5-93%§)                
Acidobacteriaf (25%; 1-92%§)   
Betaproteobacteriaf (5.0%; 0-19%§)  
Gammaproteobacteriaf               
(3.3%; 0-9%§)                           
Actinobacteriaf (1.7%; 0-13%§)             
Verrucomicrobiaf (1.5%; 0-15%§)    
Planctomycetesf (0.6%; 0-22%§)  
Bacteoidetesf (1.2%; 0-6%§)         
Deltaproteobacteriaf (0.9% 0-6%§)  
Firmicutesf (0.3; 0-2%§)   
Burkholderiaceaef (0.74%) 
Myxococcalesf (0.70%) 
Pseudomonadaceaef (0.43%) 
Actinomycetaceaef (0.04%)  
Nocardioidaceaef (0.02%) 
Pseudonocardiaceaef, 
(0.007%) 
Micromonosporaceaef 
(0.007%)          
Kineoporiaceaef (0.005%)  
Hodkinson et al 
2012 
Arthrorhaphis 
citrinella, Baeomyces 
placophyllus, B. rufus, 
Icmadophila 
ericetorum, Psora 
decipiens Trapeliopsis 
granulosa 
Styria, Austria  FISH Alphaproteobacteria           
Acidobacteria 
Not described Muggia et al 
2013 
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Rhizocarpon spp South Tyrol, 
Italy 
DGGE, 20 
sequenced 
bands 
Alphaproteobacteria 11 bands  
Acidobacteria 3 bands        
Bacteroidetes, Firmicutes, 
Cyanobacteria and Actinobacteria 1 
band. 
Not described Esposito et al 
2013 
Lobaria pulmonaria Styria, Austria  Pyro-
sequencing 
of rRNAs† 
FISH 
Alphaproteobacteriag (35%)         
Bacteroidetesg (14%)      
Verrucomicrobiag (8%) 
Deltaproteobacteriag (7.5%)             
Actinobacteriag (12%)         
Betaproteobacteriag (2.7%) 
Gammaproteobacteriag (2.4%)   
Acidobacteriag (2.3%)      
Planctomycetesg (1.2%) 
Myxococcalesg (6.9%) 
Pseudonocardiaceaeg (3.6%)  
Micromonosporaceaeg (1.3%) 
Kineoporiaceaeg (0.9 %) 
Pseudomonadaceaeg (0.8%) 
Nocardioidaceaeg (0.8%)    
Burkholderiaceaeg (0.1%) 
Streptomycetaceaeg (0.1%)   
Aschenbrenner 
et al 2014 
Peltigera 
membranaceae 
Iceland Shotgun 
pyro-
sequencing 
followed 
by rRNA 
analysis 
Alphaproteobacteria (40%)         
Bacteroidetes (14%)        
Actinobacteria  (11%)    
Betaproteobacteria (9%)  
Verrucomicrobia (8%)             
Gammaproteobacteria (5%)   
Deltaproteobacteria (3%) 
Nocardiaceaeh             
Myxococcalesh             
Burkholderialesi 
Sigurbjörnsdòttir 
et al 2015 
a. Estimated from PCR amplification with primers targeting these clades; b.Estimated from OTU table graciously provided by S. Bates; c Estimated 
from figure 3B in the reference; d. Estimated from PCR amplification with primers targeting this clade; e.Estimated from Figure 2A in the 
reference; f Estimated from the OTU table associated  with the publication; g.  Estimated from OTU table associated to the publication; h. Used as 
reference genomes i. based on blastx analysis of contigs 
* Order in the case of Myxococcales †Cyanobacteria excluded    
 
